company background image
ZIVO logo

ZIVO Bioscience OTCPK:ZIVO Stock Report

Last Price

US$8.00

Market Cap

US$22.5m

7D

-9.3%

1Y

-52.2%

Updated

26 Mar, 2024

Data

Company Financials +

ZIVO Stock Overview

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers.

ZIVO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

ZIVO Bioscience, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ZIVO Bioscience
Historical stock prices
Current Share PriceUS$8.00
52 Week HighUS$20.52
52 Week LowUS$0.48
Beta0.24
1 Month Change-15.79%
3 Month Change476.37%
1 Year Change-52.21%
3 Year Change-87.28%
5 Year Change-86.62%
Change since IPO-99.49%

Recent News & Updates

Recent updates

ZIVO Bioscience: Building An IP Portfolio For Algal Biomass Derived Ingredients

Nov 25

Shareholder Returns

ZIVOUS Personal ProductsUS Market
7D-9.3%-1.8%1.3%
1Y-52.2%-27.1%29.8%

Return vs Industry: ZIVO underperformed the US Personal Products industry which returned -27.1% over the past year.

Return vs Market: ZIVO underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is ZIVO's price volatile compared to industry and market?
ZIVO volatility
ZIVO Average Weekly Movement36.7%
Personal Products Industry Average Movement9.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: ZIVO's share price has been volatile over the past 3 months.

Volatility Over Time: ZIVO's weekly volatility has increased from 25% to 37% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a8John Paynehttps://www.zivobioscience.com

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging.

ZIVO Bioscience, Inc. Fundamentals Summary

How do ZIVO Bioscience's earnings and revenue compare to its market cap?
ZIVO fundamental statistics
Market capUS$22.46m
Earnings (TTM)-US$7.78m
Revenue (TTM)US$27.65k

803.7x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZIVO income statement (TTM)
RevenueUS$27.65k
Cost of RevenueUS$16.04k
Gross ProfitUS$11.61k
Other ExpensesUS$7.79m
Earnings-US$7.78m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.80
Gross Margin41.99%
Net Profit Margin-28,127.25%
Debt/Equity Ratio-10.9%

How did ZIVO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.